pharma · Osteoarthritis of the Knee · Multiple Sclerosis · APUS
Apimeds Pharmaceuticals US
Apimeds Pharmaceuticals US clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Matawan, USA HQ
2020 Founded
3 Employees
Public company Type
APUS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Matawan, USA
- Founded
- 2020
- Employees
- 3
- Programs
- 3
- Drugs
- 2
- Patents
- 0
Apimeds Pharmaceuticals US projects
1 ClinicalTrials.gov programs sponsored by Apimeds Pharmaceuticals US.
Apimeds Pharmaceuticals US has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Apimeds Pharmaceuticals US have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.